Scope of the Study
Hemostasis is the physiological process that helps to maintain blood in the fluid state and prevent the loss of blood from damaged blood vessels through clot formation. Many coagulation proteins are involved in the reactions that participate in the hemostatic process. Deficiencies in any of the coagulation proteins may lead to bleeding. Hemostasis valves are used in interventional and diagnostic procedures for sealing off and minimizing fluid loss. It works by reducing the opening time during wire or microcatheter insertion.
The market study is being classified by Type (One-Handed Hemostasis Valve, Hemostasis Valve Y-Connectors, Double Y-Connector Hemostasis Valves and Other), by Application (Hospitals, Clinics, Ambulatory Surgery Centers and Diagnostic Laboratories) and major geographies with country level break-up.
Medtronic, Inc. (Ireland), Boston Scientific (United States), Abbott (United States), Teleflex Incorporated (United States), B. Braun Melsungen (Germany), DeRoyal Industries, Inc. (United States), Argon Medical (United States), Freudenberg Medical (United States), Scitech (Brazil) and Merit Medical Systems, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Terumo Corporation (Japan), Shenzhen Antmed Co.,Ltd. (China) and VascuTech Medical LLC (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Hemostasis Valves market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Hemostasis Valves market by Type, Application and Region.
On the basis of geography, the market of Hemostasis Valves has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
- Increased Number of Angiography and Angioplasty Procedures Worldwide
- Availabilities of Health Care Facilities
- Rising Geriatric Population
- Trend for Innovative Medical Devices
- Risk of Air Leakage That May Cause an Air Embolism
- Rising Prevalence to Coronary Artery Disease
- Increasing Number of Hospitals Worldwide With Advanced Facilities
- Lack of Availabilities of Advanced Healthcare Facilities in Developing Countries
Market Leaders and their expansionary development strategies
On 4th October 2018, Teleflex Incorporated announced that it has acquired Essential Medical Inc., a privately-held medical device company that has developed and commercialized the CE Marked MANTA Vascular Closure Device specifically designed for closure of large bore arteriotomies following procedures utilizing devices or sheaths ranging in size from 10F to 18F.
On 30th October 2018, Freudenberg Medical launched a hemostasis valve HyperSeal XL designed to provide a robust design option for vascular access applications up to 30Fr and 40Fr.
Key Target AudienceHemostasis Valves Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase